Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 1
Submit an article Journal homepage
403
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma

Pablo Mozasa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9528-4971View further author information
ORCID Icon,
Andrea Riveroa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainView further author information
,
Alfredo Rivas-Delgadoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-0385-3415View further author information
ORCID Icon,
Ferran Nadeub Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-2910-9440View further author information
ORCID Icon,
Guillem Clotb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-2588-7413View further author information
ORCID Icon,
Juan Gonzalo Correaa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0001-6470-8102View further author information
ORCID Icon,
Carlos Castilloa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainView further author information
,
Alex Batallera Department of Hematology, Hospital Clínic de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-6085-2745View further author information
ORCID Icon,
Tycho Baumanna Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-4421-0088View further author information
ORCID Icon,
Eva Ginéa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-0532-1204View further author information
ORCID Icon,
Julio Delgadoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-5157-4376View further author information
ORCID Icon,
Neus Villamorb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;d Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainORCID Iconhttps://orcid.org/0000-0001-6538-4111View further author information
ORCID Icon,
Elías Campob Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;d Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain;e Universitat de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0001-9850-9793View further author information
ORCID Icon,
Patricia Pérez-Galánb Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainORCID Iconhttps://orcid.org/0000-0003-3895-5024View further author information
ORCID Icon,
Laura Magnanoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-6928-8386View further author information
ORCID Icon &
Armando López-Guillermoa Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain;b Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain;e Universitat de Barcelona, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-8588-8381View further author information
ORCID Icon show all
Pages 104-111 | Received 05 Aug 2020, Accepted 02 Sep 2020, Published online: 19 Sep 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Pablo Mozas & Armando López-Guillermo. (2021) Response to: The lymphocyte-to-monocyte ratio in follicular lymphoma. Leukemia & Lymphoma 62:10, pages 2562-2563.
Read now
Marc Sorigue & Juan-Manuel Sancho. (2021) The lymphocyte-to-monocyte ratio in follicular lymphoma. Leukemia & Lymphoma 62:10, pages 2558-2561.
Read now

Articles from other publishers (5)

Ana Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, Yanira Ruiz-Heredia, Sara Dorado, Gloria Figaredo, Juan Manuel Rosa-Rosa, Antonia Rodriguez, Carmen Barcena, Laura Parrilla Navamuel, Jaime Carrillo, Ricardo Sanchez, Laura Rufian, Alexandra Juárez, Margarita Rodriguez, Chongwu Wang, Paula de Toledo, Carlos Grande, Manuela Mollejo, Luis-Felipe Casado, María Calbacho, Tycho Baumann, Inmaculada Rapado, Miguel Gallardo, Pilar Sarandeses, Rosa Ayala, Joaquín Martínez-López & Santiago Barrio. (2023) Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT. Leukemia 37:3, pages 659-669.
Crossref
Chunyuan Li, Wei Zhang, Danqing Zhao, Pei Yang, Wei Wan, Shuozi Liu & Hongmei Jing. (2022) Development of a new risk scoring system based on spleen involvement and the lymphocyte/monocyte ratio for follicular lymphoma patients. Leukemia Research 123, pages 106980.
Crossref
Pablo Mozas, Andrea Rivero, Alfredo Rivas‐Delgado, Juan Gonzalo Correa, Maria Condom, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano & Armando López‐Guillermo. (2021) First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma. Hematological Oncology 40:2, pages 297-301.
Crossref
Carla Casulo. (2021) Follicular lymphoma: is there an optimal way to define risk?. Hematology 2021:1, pages 313-319.
Crossref
Cèlia Dobaño-López, Ferran Araujo-Ayala, Neus Serrat, Juan G. Valero & Patricia Pérez-Galán. (2021) Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. Cancers 13:4, pages 641.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.